The American Society of Nephrology has identified potential biomarkers for AKI detection, including cystatin C (Cyst-C), neutrophil gelatinase-associated lipocalin (NGAL), and creatinine (Cr) [19,20,21]. This evidence concerns the gene LCN2 and acute kidney injury.